Pathbreaking Biotech Investor—Dr. Beth Seidenberg—to Speak at #BIF18

The rapid pace of scientific discovery, FDA approvals, commercialization of medicines held long in pipelines, and numerous IPOs during 2018 are driving interest in the smaller private companies with the resulting investment on pace to set a record for venture capital investing in healthcare.
It is against this backdrop that the Biotechnology Innovation Organization (BIO) will host the BIO Investor Forum in San Francisco—a biotech hub—October 17th and 18th.
Dr. Beth Seidenberg, a freq